ABVC BioPharma
$0.97
21
+$0.06+6.67% Tuesday 20:00
Statistics
Day High
0.98
Day Low
0.92
52W High
5.48
52W Low
0.74
Volume
80,643
Avg. Volume
55,546
Mkt Cap
23.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Oct 13
$2.93
Apr 13
$2.83
Apr 13
$0.4
Jan 13
$3.97
Jan 13
$0.54
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
19MayExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-961.37%Profit Margin
Unprofitable1.02MRevenue
-9.81MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ABVC. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Alkermes
ALKS
Mkt Cap5.07B
AMGEN
AMGN
Mkt Cap160.66B
Lilly(Eli) &
LLY
Mkt Cap772.28B
Pfizer
PFE
Mkt Cap140.15B
Merck
MRK
Mkt Cap214.76B
Novartis
NVS
Mkt Cap237.61B
Johnson & Johnson
JNJ
Mkt Cap455.04B
Rogers
ROG
Mkt Cap1.57B
About
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.
Show more...
CEO
Mr. Eugene Jiang
Employees
16
Country
US
ISIN
US00091F3047
Listings
0 Comments
Share your thoughts
FAQ
What is ABVC BioPharma stock price today?▼
The current price of ABVC is $0.97 USD — it has increased by +6.67% in the past 24 hours. Watch ABVC BioPharma stock price performance more closely on the chart.
What is ABVC BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ABVC BioPharma stocks are traded under the ticker ABVC.
Is ABVC BioPharma stock price growing?▼
ABVC stock has fallen by -10.18% compared to the previous week, the month change is a -25.95% fall, over the last year ABVC BioPharma has showed a -26.51% decrease.
What is ABVC BioPharma market cap?▼
Today ABVC BioPharma has the market capitalization of 23.57M
When is the next ABVC BioPharma earnings date?▼
ABVC BioPharma is going to release the next earnings report on May 19, 2026.
What were ABVC BioPharma earnings last quarter?▼
ABVC earnings for the last quarter are -0.16 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ABVC BioPharma revenue for the last year?▼
ABVC BioPharma revenue for the last year amounts to 1.02M USD.
What is ABVC BioPharma net income for the last year?▼
ABVC net income for the last year is -9.81M USD.
Does ABVC BioPharma pay dividends?▼
Yes, ABVC dividends are paid quarterly. The last dividend per share was 2.93 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does ABVC BioPharma have?▼
As of April 01, 2026, the company has 16 employees.
In which sector is ABVC BioPharma located?▼
ABVC BioPharma operates in the Health Care sector.
When did ABVC BioPharma complete a stock split?▼
The last stock split for ABVC BioPharma was on July 25, 2023 with a ratio of 1:10.
Where is ABVC BioPharma headquartered?▼
ABVC BioPharma is headquartered in Fremont, US.